Ukukhanda ikhanda okuyisisekelo kuyisifo esingenasifo esiyinkimbinkimbi esiyinhloko, okusho ukuthi izinhlungu zekhanda zokugwaza azibangelwa isimo sezempilo esingaphansi. Ngamanye amazwi, lolu hlobo lwezinhlungu lukhona luqobo ngaphandle kweminye incazelo yezempilo.
Izimpawu
Izimpawu zokukhanda kwezinhloko eziyinhloko zifaka:
- Ukugwaza okulodwa noma uchungechunge lwezinhlungu zokugwaza ekhanda (njengokuthi "izinhlungu ze-ice-pick" noma "i-jabs ne-jolts").
- Ukusebenza okufushane, ngokuvamile kuhlala imizuzwana emithathu noma ngaphansi.
- Ukugwaza kubonakala ngendlela engavamile, okwenzeka kanye ngezikhathi ezimbalwa ngosuku (nakuba kungenzeka kufika ku-50 noma ngisho izikhathi eziyikhulu ngosuku).
- Ukugaya kungase kwenzeke ngokuphindaphindiwe ngaphezu kwezinsuku, kodwa lokhu akuvamile.
Ukuvama
Ochwepheshe bakholelwa ukuthi lesi sifo asivamile, nakuba izifundo ziye zaqala ukubika ukuthi zivame kangakanani (amaphesenti amabili kuya kuma-35 amaphesenti).
Isizathu
Ochwepheshe bakholelwa ukuthi umsuka walesi sihloko uncike ekucaseni kwezintambo zokugcina izintathu. Lokhu kungenxa yokuthi ubuhlungu be-disorder disorder buzwa ekusabalazweni kwegatsha lokuqala le-nerve trigeminal (ezungeze iso, ithempeli, kanye nohlangothi lwekhanda).
Ukuze kucaciswe, ukukhanda ikhanda okuyisisekelo kuyimimo ehlukile kwesinye isifo esihlobene nobuhlungu okuthiwa i-neuralgia ye-trigeminal .
Ukuxilongwa
Inhloko oyinhloko yokugwaza ingaba yinkimbinkimbi ukuxilonga, njengoba ingahlala ndawonye, futhi yenzeke kanyekanye, nezinye izinkinga zekhanda ezinjenge-migraines noma ikhanda lekhanda .
Ngaphezu komlando ophelele kanye nokuhlolwa kwezinzwa, odokotela bangenza izithombe ezifana ne-MRI scan yobuchopho ukulawula izimo ezibuhlungu ngaphambi kokuqinisekisa ukuxilongwa.
Ukwelapha
Uma kutholakala, ukwelashwa kungase kuhlanganise ukuthatha i-Tivorbex (i-indomethacin), okuyinto imithi engeyona i-steroidal anti-inflammatory ( NSAID ).
Kodwa-ke, i-indomethacin ingase ingasebenzi kwabanye abantu, kuze kube yiyodwa kweyesithathu, futhi ingabangela imiphumela enobungozi yezinso noma emathunjini.
Ezinye izidakamizwa ezingase zibe khona udokotela angabekezela ukukhanda ikhanda okuyisisekelo zihlanganisa:
- I-celebrex (celecoxib): i- COX-2 inhibitor
- I-Neurontin (gabapentin)
- I-Melatonin
Ukuxhumana Okuzenzakalelayo
Isayensi ibonisa ukuthi kwabanye abantu kungenzeka kube nokuxhumana phakathi kwesifo sabo sokuzimela kanye nesifo esiyinhloko sokugwaza. Isifo esizimele ngokuzenzakalelayo yisimo esibonakala ngesimiso somzimba sokuzivikela somuntu esihlasela izivalo ezivamile, ezempilo. Isibonelo, ku- multiple sclerosis , amangqamuzana omzimba omzimba ahlasela ukumbozwa kwezinzwa ebuchosheni nasendlini yomgogodla.
Ucwaningo olulodwa lwesiNtaliyane ku- Clinical Neurology ne-Neurosurgery luhlolisise abantu abangu-26 abanesifo sokukhanda okuyinhloko. Abacwaningi bathola ukuthi kulaba bantu abangu-26, abangu-14 banesifo sokuzimela. Ngaphezu kwalokho, abayisikhombisa kulabo bantu abangu-14 babe nobufakazi bokulahlekelwa kwe-myelin (okubizwa ngokuthi ukudilizwa phansi) ku-MRI. Labo abanegunya lokuxoshwa kwabantu babandakanya abantu abane-MS, iSjogren's syndrome, noma i-vasculitis.
Abanye abantu abayisikhombisa abanesifo esiyinhloko sokugwaza ikhanda kanye nesifo sokuzimela bengenalo ubufakazi bokudilizwa kwe-MRI.
Laba bantu babe nezimo ezilandelayo ezizenzakalelayo:
- Isifo se-Lyme
- I-Systemic lupus erythematosus
- Isifo sikaBehcet
- Antiphospholipid antibody syndrome
- I-Vasculitis
- I-syndrome ye-clinically-isolated (isiqephu sokuqala se-multiple sclerosis)
Indlela ecacile phakathi kokuthi lezi zimo zingabangela kanjani ukushaywa ikhanda kungacacile, kodwa ngokusekelwe ekutholeni ukuthungulwa kwabangu-7 kwabahlanganyeli, abalobi bacabanga ukuthi ukulimala okwehliswa phansi kwesimo sobuchopho kungase kube nomthwalo wemfanelo.
Kuthiwani ngabanye abayisikhombisa ababengenalo ukutholwa phansi kwesinqumo? Kunzima ukukusho, kodwa abalobi basikisela ukuthi kungenzeka ukuthi ukudilizwa phansi kungatholakali kuMRI.
Olunye ucwaningo, olwaluyinkinga yocala (umbiko wesiguli ngasinye), wathola inhlangano phakathi kwekhanda lokushaya ikhanda lokuqala kanye ne-multiple sclerosis. Kulesi sifundo, owesifazane osemusha wenza iziqephu zokushaya ikhanda, izikhathi ezingaba ngu-100 ngosuku.
Phakathi nesinye isiqephu, izinhlungu zekhanda ezihlabayo zazihlotshaniswa nokugubha nokugubha kwesandla sakhe sokunene. Amakhanda akhe kanye nezimpawu zezinzwa zixazululwe nge-steroids, esetshenziselwa ukwelashwa kabusha kwe-multiple sclerosis .
Khumbula, inhlangano ayisho ukuthi i-causation. Ngenxa yokuthi ugwaze ikhanda akusho ukuthi unayo isimo sokuzimela futhi ngokuphambene nalokho. Lokhu kungumxhumanisi othakazelisayo futhi uvumela ucwaningo olwengeziwe ukuqonda kangcono ukuthi "kungani" ngemuva kwalo.
Lokhu kuthiwa, lokhu kuxhumano kungabuye kuguqule ukuthi udokotela wakho uphatha kanjani ikhanda lakho lokushaya. Ngokwesibonelo, angase acabangele i-steroids yokunciphisa ubuhlungu bekhanda lakho lokushaya uma nawe unesimo sokuzimela.
Izwi elivela
Njengokwenza njalo, khuluma nodokotela wakho uma unesifo sokukhathazeka kwezokwelapha ukuze uhlaziye kahle futhi uphathe ukwelashwa. Uma kuziwa emakhanda okugwaza okuyinhloko, izindaba ezinhle ukuthi abantu abaningi ababona izimpawu eziphikisayo, kodwa uma benza, kunezinye izinketho zokwelashwa eziphumelelayo.
> Imithombo:
> Applebee, A. (2012). Ukwelashwa komtholampilo we-multiple sclerosis kanye nekhanda. U-Headache , Okthoba; 52 Ukusekela 2: 111-6.
> Fuh, JL, Kuo, KH, (2007). Wang SJ. Ukushaya ikhanda okuyisisekelo emtholampilo wekhanda. I-Cephalalgia, Sep; 27 (9): 1005-9.
> Ikomidi Lokuhlukanisa Amakhanda Ye-International Headache Society. (2013). "I-International Classification of Headache Disorders: I-3rd Edition (i-beta version)". I-Cephalalgia, 33 (9): 629-808.
> Klein, M., Woehr, B, Zeller, G., & Straube, A. (2013). Ukushaya ikhanda njengesibonakaliso sokubuyiselwa kwe-Multiple Sclerosis. Inhloko, Jun; 53 (7): 1159-61.
> Rampello, L., Malaguarnera, M., Rampello, L., Nicoletti, G., & Battaglia, G. (2012). Ukushaya ikhanda kumagciwane anezinkinga ezizenzakalelayo. I-Neurology Clinic ne-Neurosurgery. 2012 Jul; 114 (6): 751-3.